Tag: venous thromboembolism

VTE working group

Experts establish international standard set of outcome measures for patients with...

The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
DVT

Key differences in presentation, outcomes for distal versus proximal DVT uncovered

A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
Roshan Bootun application of compression stockings

Compression duration affects pain following superficial venous intervention, study finds

Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...
Inari Medical

Inari Medical announces leadership succession plan

This week Inari Medical announced that chief operating officer Drew Hykes will succeed Bill Hoffman as chief executive officer, effective 1 January 2023. Hykes...
Thrombolex bashir

Michael Cerminaro to succeed Marvin Woodall as CEO of Thrombolex

Thrombolex has announced that its board of directors has named Michael Cerminaro chief executive officer (CEO) effective 13 July 2022, the date of the...
ATTRACT trial

VTE: Fewer recurrences with low-dose apixaban compared to discontinuation of the...

Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...

FDA approves two paediatric venous thromboembolism indications for Janssen’s Xarelto

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the US Food and Drug Administration (FDA) has approved two paediatric indications for...

Thromboprophylaxis with anticoagulants “likely effective” at preventing VTE post-vascular surgery, larger...

“Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend towards reduced incidence of VTE when compared to placebo,” Tarek Haykal (Duke...
kirill lobastov

Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in...

Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a...
cancer patient

Mayo Clinic study provides clarity on use of anticoagulants to treat...

A study by Mayo Clinic researchers provides some clarity on the use of direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, to treat...
guidelines

Study launched to assess blood clot prediction model for paediatric patients

Monroe Carell Jr Children's Hospital at Vanderbilt (Nashville, USA) has launched a study to determine the impact of a predictive model for identifying paediatric...

Recent advances in VTE management provide much-needed clarity, but more needs...

Manjit Gohel (Cambridge, UK) and Stephen Black (London, UK) write that several recent advances in the management of venous thromboembolism (VTE) have provided clarity...
COVID-19

Further research will soon generate standardised approach to VTE in COVID-19...

At VENOUS2021 (17–20 March, virtual), the annual meeting of the American Venous Forum, Geno Merli (Thomas Jefferson University Hospital, Philadelphia, USA) gave a keynote...

Interview: Comprehensive, patient-friendly risk assessment “crucial” to VTE prevention

From the first research linking heparin to a reduction in fatal pulmonary embolism (PE), to the development and refinement of risk assessment tools to...
geko OnPulse

Marathon Medical wins inclusion of the Geko device on its Veterans...

Sky Medical Technology has announced the inclusion of its flagship product, the Geko device, on a US Veterans Health Administration (VA) Federal Supply Schedule...
cancer patient

High thrombotic risk in cancer patients receiving immunotherapy

According to a recent study, patients with cancer under immune checkpoint inhibitor therapy are at high risk of thromboembolism, especially venous thromboembolism (VTE). Furthermore,...

Meta-analysis: IVC filters should be considered for certain patients at high...

In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...

DIVERSITY trial finds adjusted dabigatran dosing algorithm appropriate for treatment of...

In a recent randomised controlled trial, an age-adjusted, weight-adjusted dabigatran dosing algorithm was found to be appropriate in children under 18 years old with...

VTE-related factors and elevated bleeding risk associated with IVC filter placement...

In a recent study, factors related with venous thromboembolism (VTE) severity—including pulmonary embolism response team (PERT) referral from the intensive care unit (ICU) and...
cancer patient

Comparable risk of recurrent VTE between patients with unprovoked VTE and...

Patients with venous thromboembolism (VTE) carry a high risk of recurrence. Accordingly, a 16-year Danish prospective cohort study of nearly 74,000 patients with incident VTE...
guidelines

Society of Interventional Radiology publishes IVC filter guidelines

The Society of Interventional Radiology (SIR) recently published new clinical practice guidelines that provide evidence-based recommendations on the use of inferior vena cava (IVC)...
cancer patient

DOACs show promise over heparin injections in meta-analysis comparing cancer-associated VTE...

A recent meta-analysis found that direct oral anticoagulants (DOACs) appear to be a “reasonable alternative” to low molecular weight heparin (LMWH) for the treatment...
COVID-19

COVID-19 associated VTE: International thrombosis community urge WHO to act

The International Society on Thrombosis and Haemostasis (ISTH), on behalf of the international thrombosis community, have called on the World Health Organisation (WHO) to...

Study reports low rates of bleeding and VTE after 12 months...

Daiichi Sankyo Europe GmbH has announced results from five analyses of 12-month data from ETNA-VTE (Edoxaban treatment in routine clinical practice in patients with...

AHA and ISTH release joint statement on future VTE research priorities

The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) have released a joint scientific statement identifying the top five priorities for...

American Heart Association issues call to action to prevent VTE in...

Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the USA and worldwide. A new policy statement by the American Heart...
geko OnPulse

Geko device represents an alternative to IPC devices during COVID-19

Sky Medical Technology highlights a publication on 5 May 2020 in the Journal of Thrombosis and Haemostasis showing the incidence of venous thromboembolism (VTE) in...
compression

Compression stockings might not be needed to prevent blood clots after...

Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...
COVID-19

New study addresses thromboembolic complications in COVID-19 patients

There is an “urgent need” to improve specific venous thromboembolism (VTE) diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19...

AVF releases white paper on considerations in prophylaxis and treatment of...

The COVID-19 subcommittee of the American Venous Forum (AVF) has issued a white paper on considerations in prophylaxis and treatment of venous thromboembolism (VTE)...
VTE treatment guideline with Anna Falanga and Nigel S Key

Updated VTE treatment guideline for patients with cancer revealed by ASCO

An updated guideline on the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer has been unveiled by the American Society of...
reduced hospital time and costs Xarelto

Paediatric trial finds rivaroxaban similar to standard anticoagulation in treatment of...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing paediatric patients (aged birth to...

Increased risk of VTE found in critically ill H1N1 patients with...

A new study has found that intensive care unit patients with swine flu (H1N1) and acute respiratory distress syndrome (ARDS) were 33 times more...
how is lower levels of serum bilirubin and venous thromboembolism related

Study finds significant association between low bilirubin levels and venous thromboembolism

A recent paper published by Hakan Duman (Recep Tayyip Erdoğan University, Rize, Turkey) and colleagues in the Journal of Vascular Surgery: Venous and Lymphatic...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...

Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...
Venous News for specialists

Inari Medical announces completion of enrolment in the FLARE study for...

Inari Medical has announced that it has completed enrolment of its investigational device exemption (IDE) study. The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study...

More evidence that statins could prevent blood clots in the veins

Further evidence has been found by researchers at the UK’s University of Leicester and University of Bristol to suggest statins could "significantly reduce" the...

Canadian study finds rivaroxaban more effective at preventing recurrent blood clots...

A Canadian-led international research team has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of...
Venous News for specialists

Use of computerised systems may help identify patients at decreased risk...

The use of computerised clinical decision support systems among surgical patients are associated with a significant increase in the proportion of patients with adequately...
Venous News for specialists

First patient enrolled in Daiichi Sankyo European edoxaban registry

The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...